| Autor: |
Vaskinn A; Norwegian Centre for Mental Disorders Research, Oslo University Hospital, Oslo, Norway. anja.vaskinn@medisin.uio.no.; Department of Psychology, University of Oslo, Oslo, Norway. anja.vaskinn@medisin.uio.no., Løvgren A; Norwegian Centre for Mental Disorders Research, Oslo University Hospital, Oslo, Norway., Egeland MK; Norwegian Centre for Mental Disorders Research, Oslo University Hospital, Oslo, Norway.; Department of Psychology, University of Oslo, Oslo, Norway., Feyer FK; Norwegian Centre for Mental Disorders Research, Oslo University Hospital, Oslo, Norway., Østefjells T; Norwegian Centre for Mental Disorders Research, Oslo University Hospital, Oslo, Norway.; Department for Specialized Inpatient Treatment, Division of Mental Health and Addiction, Akershus University Hospital, Lørenskog, Norway., Andreassen OA; Norwegian Centre for Mental Disorders Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Melle I; Norwegian Centre for Mental Disorders Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Sundet K; Norwegian Centre for Mental Disorders Research, Oslo University Hospital, Oslo, Norway.; Department of Psychology, University of Oslo, Oslo, Norway. |
| Abstrakt: |
Schizophrenia is characterized by social cognitive impairments that predict functioning. Social cognitive training aims to target these impairments. Although it can improve the targeted social cognitive domain, it is unclear if the training generalizes to non-targeted domains and to functioning, with lasting effects. This randomized controlled trial examined the effect of a targeted facial affect recognition training program, Training of Affect Recognition (TAR), in persons with schizophrenia. Individuals with schizophrenia were randomized to receive treatment as usual and TAR (n = 24) or treatment as usual (n = 24) after assessments with a comprehensive protocol at baseline (T1). Participants were reassessed immediately after the intervention period (T2: after 8 weeks) and at 3-month follow-up (T3). The protocol included tests of social cognition (facial or body affect recognition, theory of mind), nonsocial cognition (Matrics Consensus Cognitive Battery), clinical symptoms (Positive and Negative Syndrome Scale, Calgary Depression Scale for Schizophrenia), functioning (self-reported, social or nonsocial functional capacity), self-esteem, self-efficacy and insight. Linear mixed models yielded a significant group × time interaction effect for a non-targeted social cognitive domain (theory of mind) and a trend-level effect for social functional capacity with the intervention group performing better over time. No beneficial effects on nonsocial cognition, other measures of functioning, clinical symptoms, or self-esteem/self-efficacy appeared for the TAR program. This study provides evidence for transfer and durability effects of facial affect recognition training to theory of mind, but also highlights the need for additional treatments to achieve functional benefits. |
